Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1

Gut

Volumn 59, Issue 9, 2010, Pages 1226-1235

  Zhao, Liang ^a   Wang, Hui ^b   Liu, Chao ^a   Liu, Yawei ^a   Wang, Xiaoyan ^a   Wang, Shuang ^a   Sun, Xuegang ^a   Li, Jianming ^a   Deng, Yongjian ^a   Jiang, Yong ^a   Ding, Yanqing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIM PROTEIN; PROTEIN SH3; CYTOSKELETON PROTEIN; LASP1 PROTEIN, HUMAN; MESSENGER RNA; RNA; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; DISEASE ASSOCIATION; DNA LIBRARY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RNA INTERFERENCE; ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; COLORECTAL TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PROCEDURES; PROGNOSIS; TUMOR CELL CULTURE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIM DOMAIN PROTEINS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PHENOTYPE; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 77956130440     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.202739     Document Type: Article

References (40)

1. Zhao L, Wang H, Deng YJ, et al. Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients. Mod Pathol 2009;22:786-96.
2. Zhao L, Wang H, Li J, et al. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumour progression and poor prognosis of colorectal cancer. J Proteome Res 2008;7:3994-4003.
3. Grunewald TG, Kammerer U, Schulze E, et al. Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells. Exp Cell Res 2006;312:974-82.
4. Grunewald TG, Kammerer U, Winkler C, et al. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br J Cancer 2007;96:296-305.
5. Tomasetto C, Moog-Lutz C, Regnier CH, et al. Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains. FEBS Lett 1995;373:245-9.
6. Tomasetto C, Regnier C, Moog-Lutz C, et al. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localised to the q11-q21.3 region of chromosome 17. Genomics 1995;28:367-76.
7. Schreiber V, Moog-Lutz C, Regnier CH, et al. Lasp-1, a novel type of actin-binding protein accumulating in cell membrane extensions. Mol Med 1998;4:675-87.
8. Keicher C, Gambaryan S, Schulze E, et al. Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase. Biochem Biophys Res Commun 2004;324:308-16. (Pubitemid 39311495)
9. Chew CS, Chen X, Parente JA Jr, et al. Lasp-1 binds to non-muscle F-actin in vitro and is localized within multiple sites of dynamic actin assembly in vivo. J Cell Sci 2002;115:4787-99.
10. Butt E, Gambaryan S, Gottfert N, et al. Actin binding of human LIM and SH3 protein is regulated by cGMP- and cAMP-dependent protein kinase phosphorylation on serine 146. J Biol Chem 2003;278:15601-7.
11. Rachlin AS, Otey CA. Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin. J Cell Sci 2006;119:995-1004.
12. Li B, Zhuang L, Trueb B. Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J Biol Chem 2004;279:20401-10.
13. Chew CS, Parente JA Jr, Zhou C, et al. Lasp-1 is a regulated phosphoprotein within the cAMP signaling pathway in the gastric parietal cell. Am J Physiol 1998;275:C56-67. (Pubitemid 128731355)
14. Chew CS, Parente JA Jr, Chen X, et al. The LIM and SH3 domain-containing protein, lasp-1, may link the cAMP signaling pathway with dynamic membrane restructuring activities in ion transporting epithelia. J Cell Sci 2000;113:2035-45.
15. Lin YH, Park ZY, Lin D, et al. Regulation of cell migration and survival by focal adhesion targeting of Lasp-1. J Cell Biol 2004;165:421-32.
16. Zhang YF, Liu L, Ding YQ. Isolation and characterization of human colorectal cancer cell subline with unique metastatic potential in the liver. Nan Fang Yi Ke Da Xue Xue Bao 2007;27:126-30.
17. Coppola D, Szabo M, Boulware D, et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumour histologies. Clin Cancer Res 2004;10:184-90.
18. Li D, Li JQ, Ouyang SG, et al. An integrated strategy for functional analysis in large-scale proteomic research by gene ontology. Progr Biochem Biophys 2005;32:1026-9.
19. Van den Bergh G, Arckens L. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr Opin Biotechnol 2004;15:38-43. (Pubitemid 38224247)
20. Kakisaka T, Kondo T, Okano T, et al. Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J Chromatogr B 2007;852:257-67.
21. Friedman DB, Hill S, Keller JW, et al. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2004;4:793-811.
22. Urano T, Saito T, Tsukui T, et al. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 2002;417:871-5.
23. Ohuchida K, Mizumoto K, Ohhashi S, et al. S100A11, a putative tumour suppressor gene, is overexpressed in pancreatic carcinogenesis. Clin Cancer Res 2006;12:5417-22.
24. Li GC, Guan LS, Wang ZY. Overexpression of RbAp46 facilitates stress-induced apoptosis and suppresses tumorigenicity of neoplastigenic breast epithelial cells. Int J Cancer 2003;105:762-8.
25. Tang YS, Zhang YP, Xu P. hNUDC promotes the cell proliferation and differentiation in a leukemic cell line via activation of the thrombopoietin receptor (Mpl). Leukemia 2008;22:1018-25.
26. Chen YQ, Li TY, Qu SH, et al. Expression and effects of nuclear distribution C (NUDC) protein in nasopharyngeal carcinoma cell lines. Ai Zheng 2006;25:708-12.
27. McConnell JE, Armstrong JF, Hodges PE, et al. The mouse 14-3-3 epsilon isoform, a kinase regulator whose expression pattern is modulated in mesenchyme and neuronal differentiation. Dev Biol 1995;169:218-28.
28. Siegenthaler G, Hotz R, Chatellard-Gruaz D, et al. Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro. Biochem J 1994;302:363-71. (Pubitemid 24280086)
29. Kim JH, Kim CN, Kim SY, et al. Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer. Oncol Rep 2009;22:41-7.
30. Min HS, Choe G, Kim SW, et al. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid. Mod Pathol 2008;21:748-55.
31. Garrett SC, Varney KM, Weber DJ, et al. S100A4, a mediator of metastasis. J Biol Chem 2006;281:677-80.
32. Li DJ, Deng G, Xiao ZQ, et al. Identificating 14-3-3 sigma as a lymph node metastasis-related protein in human lung squamous carcinoma. Cancer Lett 2009;279:65-73.
33. Yi B, Tan SX, Tang CE, et al. Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma. J Cell Biochem 2009;106:858-66.
34. Tanaka K, Hatada T, Kobayashi M, et al. The clinical implication of 14-3-3 sigma expression in primary gastrointestinal malignancy. Int J Oncol 2004;25:1591-7.
35. Wang YF, Chow KC, Chang SY, et al. Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. Br J Cancer 2004;90:2186-93.
36. Wang YF, Chen JY, Chang SY, et al. Nm23-H1 expression of metastatic tumours in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma. Int J Cancer 2008;122:377-86.
37. Wang LS, Chow KC, Lien YC, et al. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma. Eur J Cardiothorac Surg 2004;26:419-24.
38. Wu M, Bai X, Xu G, et al. Proteome analysis of human androgen-independent prostate cancer cell lines: variable metastatic potentials correlated with vimentin expression. Proteomics 2007;7:1973-83.
39. Wang JW, Peng SY, Li JT, et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett 2009;281:71-81.
40. Coghlin C, Carpenter B, Dundas SR, et al. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J Pathol 2006;210:351-7.